CT Perfusion Parameters Predict Vascular Pattern in Hepatocellular Carcinoma
NCT04715321 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2021-12-29
Summary
Distinct vascular patterns (ECTC or Non-ECTC) of tumors plays an important role in tumor migration, metastasis and drug resistant in hepatocellular carcinoma (HCC). However, there is no non-invasive method to predict vascular pattern in clinical. In the present study, we prospectively assess CT perfusion parameters for evaluation of the vascular pattern in HCC.
Conditions
Interventions
- OTHER
-
CT perfusion examination
CT perfusion was performed with a 64-section multidetector CT scanner. The following CT parameters were used to acquire dynamic data: blood flow (BF), blood volume (BV), mean transit time (MTT), permeability-surface area product (PS), hepatic artery ejection fraction (HAF), hepatic artery perfusion (HAP), and hepatic portal vein perfusion (PVP). And we used these parameters to predict the vascular pattern.
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-15
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- China
Study Locations
More Related Trials
-
Follow up After TACE by Elastography and Color Doppler.
NCT06070623 ·Status: NOT_YET_RECRUITING
-
Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas
NCT04813432 ·Status: UNKNOWN
-
Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma
NCT07030842 ·Status: COMPLETED
-
Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction Angiography
NCT05304572 ·Status: COMPLETED
-
Correlation Between CEUS Identification of Nodular HPD on CE-MRI and Hepatic Malignant Lesions
NCT06816212 ·Status: ENROLLING_BY_INVITATION
-
Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation
NCT02046356 ·Status: UNKNOWN
-
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma
NCT04076631 ·Status: UNKNOWN
-
Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases
NCT01631318 ·Status: COMPLETED ·Phase: NA
-
Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study
NCT04640363 ·Status: UNKNOWN
-
The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma
NCT03793322 ·Status: UNKNOWN ·Phase: PHASE1
-
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
NCT02074202 ·Status: UNKNOWN ·Phase: PHASE3
-
Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy
NCT01281683 ·Status: UNKNOWN
-
Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma
NCT03754192 ·Status: UNKNOWN ·Phase: NA
-
Shear-wave Elastography Diffuse Liver Disease
NCT05163132 ·Status: UNKNOWN
-
Evaluation of Liver Stiffness by Ultrasound Elastography for Predicting Early HCC Recurrence After Treatment
NCT04552236 ·Status: UNKNOWN
-
Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma
NCT03110068 ·Status: UNKNOWN
-
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
NCT07170345 ·Status: RECRUITING
-
Quantitative MRI Imaging in Diffuse Liver Diseases
NCT04626492 ·Status: UNKNOWN
-
A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver Injury
NCT07050550 ·Status: RECRUITING
-
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
NCT03635541 ·Status: UNKNOWN
-
Neutrophil Extracellular Traps as a Biomarker to Predict Portal Vein Tumor Thrombosis in Patients With Hepatocellular Carcinoma
NCT05040347 ·Status: COMPLETED
-
Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications
NCT02936856 ·Status: UNKNOWN ·Phase: NA
-
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
NCT03880721 ·Status: UNKNOWN
-
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
NCT02550613 ·Status: UNKNOWN
-
Relationship Between FGF19 Overexpression and Disease Prognosis
NCT06938451 ·Status: NOT_YET_RECRUITING